- Investing Ideas
- Danish Pharmaceuticals & Biotech Most Popular Stocks
Danish Pharmaceuticals & Biotech Most Popular Stocks
Results
12
Most Popular Stocks on the market
12 companies
Novo Nordisk
Market Cap: DKK 1.1t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NOVO B
DKK 245.45
7D
3.0%
1Y
-61.1%
Genmab
Market Cap: DKK 110.3b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,793.50
7D
-2.2%
1Y
8.4%
ALK-Abelló
Market Cap: DKK 49.4b
An allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.
ALK B
DKK 223.00
7D
6.4%
1Y
53.5%
H. Lundbeck
Market Cap: DKK 37.4b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 38.52
7D
-1.6%
1Y
-2.7%
Zealand Pharma
Market Cap: DKK 26.2b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 371.50
7D
3.3%
1Y
-33.1%
Bavarian Nordic
Market Cap: DKK 14.6b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 188.40
7D
-4.3%
1Y
12.2%
ChemoMetec
Market Cap: DKK 7.5b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 428.60
7D
11.3%
1Y
-24.5%
Gubra
Market Cap: DKK 6.4b
A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.
GUBRA
DKK 393.60
7D
20.8%
1Y
-26.8%
BioPorto
Market Cap: DKK 454.5m
An in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the onset of disease states for management and therapies in Europe, North America, Asia, and internationally.
BIOPOR
DKK 0.92
7D
-1.0%
1Y
-41.1%
Pharma Equity Group
Market Cap: DKK 119.6m
Through its subsidiary, Reponex Pharmaceuticals A/S, a clinical-stage biopharmaceutical company, develops treatments for diseases that have patient and social impact for which current therapy is lacking or in need of improvement.
PEG
DKK 0.097
7D
-0.6%
1Y
-29.9%
Stenocare
Market Cap: DKK 53.8m
Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally.
STENO
DKK 1.25
7D
-9.5%
1Y
209.7%
Strategic Partners
Market Cap: DKK 24.2m
Does not have significant operations.
STRAP
DKK 580.00
7D
-7.1%
1Y
-24.5%